rosacea 1st October 2019

Banish Rosacea with Dr Firas Al-Niaimi

What is Rosacea?

Red cheeks are often a sign of embarrassment. But for those with the skin condition Rosacea, blushing can be the cause of their embarrassment, rather than the effect. Rosacea is a skin condition mainly affecting the face, characterised by the skin flushing, becoming red and sore, or covered in a rash of bumpy spots. The condition affects more women than men, although men tend to experience more severe symptoms.

The cause of rosacea is not known. Antibiotics have proven helpful in clearing the initial rash, however, there is no known cure. The condition flares up time and time again. It has been linked to various triggers, including alcohol, exercise, high and low temperatures, spicy food and stress.

VBeam Prima for Rosacea

VBeam Prima is a laser treatment which effectively reduces the appearance of rosacea. Offering dual wavelengths and a maximum spot size of 15mm, VBeam Prima can target different skin depths, quickly and efficiently. Clinical studies have shown an improvement in rosacea symptoms by more than 40%, with patients reporting minimal adverse side effects. Dr Firas Al-Niaimi is currently the only cosmetic dermatologist in the UK with access to the VBeam Prima for his patients.

Anti-Wrinkle Solutions for Rosacea

Anti-wrinkle treatments are a popular non-surgical cosmetic option and are often associated with the appearance of wrinkles. The use of anti-wrinkle solutions in treating other skin conditions is becoming more widespread. Research suggests that anti-wrinkle solutions may stop the facial blood vessels from dilating, therefore reducing red, flushed skin. The effects may last for up to four months.

If you suffer from Rosacea, and antibiotics and creams are not providing you with enough relief, consider your cosmetic treatment options. Seek the professional medical advice of Dr Firas Al-Niaimi, a leading laser dermatologist and expert in the treatment of skin conditions, based in Harley Street. Make your enquiry today.

Back to blog